Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome.
about
Phase II study of everolimus in children and adults with neurofibromatosis type 2 and progressive vestibular schwannomas.Depression among adults with neurofibromatosis type 1: prevalence and impact on quality of lifeClinical features of schwannomatosis: a retrospective analysis of 87 patientsQuality of Life in Adults with Neurofibromatosis 1 in Brazil.Neurofibromatosis Clinic: A Report on Patient Demographics and Evaluation of the Clinic.The relaxation response resiliency program (3RP) in patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis: results from a pilot study.The Impact of Neurofibromatosis Type 1 on the Health and Wellbeing of Australian Adults.Examining perceived cancer risk among patients with neurofibromatosis type 1.The impact of a mind-body program on multiple dimensions of resiliency among geographically diverse patients with neurofibromatosis.Appearance concerns among women with neurofibromatosis: examining sexual/bodily and social self-consciousness.Neurodevelopmental disorders in children with neurofibromatosis type 1.First use of patient reported outcomes measurement information system (PROMIS) measures in adults with neurofibromatosis.Knowledge and Self-Esteem of Individuals with Neurofibromatosis Type 1 (NF1).RASopathies are associated with a distinct personality profile.Multiparametric whole-body anatomic, functional, and metabolic imaging characteristics of peripheral lesions in patients with schwannomatosis.
P2860
Q30422022-9BD3EAA4-9C11-45A6-80AF-8A88CF350208Q36069942-6F34E50A-CFC0-483B-9BDA-5A06366854E2Q36349611-AE562657-BF45-46AE-BD9C-4C28A30E3424Q38899618-5546F031-2101-4512-9A7E-463B1A828C6BQ39207965-767D29F9-C68C-4E7F-8C89-1D363281D1CBQ39266770-EEC66C92-63B2-46F8-A808-FFE1BC52DEAEQ41039624-CAF64AFE-4991-409B-8DD0-A032608113E0Q45117426-AE70C4BB-7047-4A0C-ABB1-6CCF6559FB4EQ47252698-04CC96C0-FBD1-44C3-8EA7-5B304DD6D767Q47626239-0A3DC036-14BE-4F80-AE34-8703A053F4DAQ47723947-F3E018A7-8CFB-4A3C-87D6-0D0A75DBE31FQ47864785-B6521159-175C-4BAA-B750-EF69B0FFE670Q50125814-5DBB843A-C927-49AD-BB5A-240C4E1BF6DAQ52320476-93E06C33-C59C-42C5-A4EE-F317068532E9Q52984278-9E6724B7-5D8C-4CA0-8B11-C6ECBDA70F37
P2860
Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome.
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome.
@ast
Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome.
@en
type
label
Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome.
@ast
Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome.
@en
prefLabel
Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome.
@ast
Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome.
@en
P2093
P2860
P356
P1433
P1476
Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome.
@en
P2093
Alona Muzikansky
Daphne L Wang
Elyse R Park
Fawn A Leigh
Kelly B Smith
Scott R Plotkin
Sonia Esparza
P2860
P2888
P304
P356
10.1038/GIM.2012.85
P407
P577
2012-08-09T00:00:00Z
P5875
P6179
1044415854